GlassScriptPhysician profile
Cataldo Cacace
NPI 1740252907
$1,970.86
in general payments reported to CMS, 2019-2025
17 companies · $87.14 in 2025
The $87.14 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2020: $88.00 · 2021: $343 · 2022: $282 · 2023: $488 · 2024: $443 · 2025: $87.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $770 · Education: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $770.14 |
| Education | $247.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $520.87 | 2019-2025 | Padcev, Myrbetriq |
| Janssen Biotech, INC. | $436.89 | 2019-2025 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $288.91 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $249.95 | 2023-2024 | Gemtesa |
| Tolmar, INC. | $62.19 | 2023-2024 | |
| Urovant Sciences INC | $60.86 | 2022 | |
| Pfizer INC. | $57.74 | 2020-2023 | |
| Sun Pharmaceutical Industries INC. | $54.80 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $41.10 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $40.81 | 2019-2020 | |
| Teleflex LLC | $39.13 | 2024 | Urolift |
| Tolmar Pharmaceuticals, INC. | $27.31 | 2020-2022 | |
| Axonics, INC. | $24.33 | 2023 | Axonics, Bulkamid |
| Medtronic USA, INC. | $23.12 | 2020 | |
| Abbvie INC. | $15.55 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $14.02 | 2020 | |
| Ferring Pharmaceuticals INC. | $13.28 | 2024 | Adstiladrin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cataldo Cacace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.